Vijaya Diagnostic Centre Ltd.

NSE: VIJAYA BSE: 543350 SECTOR: Hospital & Healthcare Services  123k   167   33

392.20
+11.90 (3.13%)
NSE: Today, 09:08 AM

Price Summary

Today's High

₹ 392.2

Today's Low

₹ 392.2

52 Week High

₹ 528

52 Week Low

₹ 295

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

4003.23 Cr.

Enterprise Value

3817.18 Cr.

No. of Shares

10.21 Cr.

P/E

50.18

P/B

7.73

Face Value

₹ 1

Div. Yield

0.26 %

Book Value (TTM)

₹  50.72

CASH

186.06 Cr.

DEBT

0 Cr.

Promoter Holding

55.01 %

EPS (TTM)

₹  7.82

Sales Growth

22.75%

ROE

26.12 %

ROCE

38.68%

Profit Growth

30.53 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year22.75%
3 Year17.34%
5 YearNA

Profit Growth

1 Year30.53%
3 Year30.25%
5 YearNA

ROE%

1 Year26.12%
3 Year25.69%

ROCE %

1 Year38.68%
3 Year36.89%

Debt/Equity

0

Price to Cash Flow

25.74

Interest Cover Ratio

9.8819114643569

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2023 55.01 0
Dec 2022 55.01 0
Sep 2022 55.01 0
Jun 2022 55.04 0
Mar 2022 54.78 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 30.2544450567632% for the Past 3 years.
  • The company has shown a good revenue growth of 17.3395481328759% for the Past 3 years.
  • Company has been maintaining healthy ROE of 25.6853785138867% over the past 3 years.
  • Company has been maintaining healthy ROCE of 36.8923802073375% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 9.8819114643569.
  • The company has an efficient Cash Conversion Cycle of -98.4344866929197 days.
  • Company has a healthy liquidity position with current ratio of 4.17221453183426.
  • The company has a high promoter holding of 55.01%.

 Limitations

  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high PE of 50.18.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
Net Sales 108.31 113.74 102.01 118.27 110.97
Total Expenditure 61.12 66.68 62.79 70.3 67.28
Operating Profit 47.19 47.06 39.22 47.97 43.69
Other Income 3.2 3.31 2.93 3.39 3.72
Interest 4.14 4.3 4.74 4.85 5.53
Depreciation 12.87 15.15 14.07 15.8 20.2
Exceptional Items 0 0 0 0 0
Profit Before Tax 33.38 30.93 23.34 30.7 21.68
Tax 8.35 7.46 6.14 7.77 5.52
Profit After Tax 25.03 23.47 17.21 22.94 16.16
Adjusted EPS (Rs) 2.45 2.3 1.69 2.25 1.58

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 279.08 328.65 367.32 450.88
Total Expenditure 187.25 196.2 204.02 251.02
Operating Profit 91.83 132.45 163.3 199.86
Other Income 8.64 11.79 10.83 12.92
Interest 4.36 14.82 14.81 16.26
Depreciation 25.69 47.67 49.73 52.14
Exceptional Items 0 0 0 0
Profit Before Tax 70.41 81.75 109.59 144.38
Tax 21.49 20.51 26.76 36.28
Net Profit 48.92 61.24 82.82 108.1
Adjusted EPS (Rs.) 4.8 6.01 8.12 10.6

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 6.94 4.53 4.53 10.2
Total Reserves 209.04 272.97 356.02 459.78
Borrowings 27.9 18.81 0 0
Other N/C liabilities 7.27 125.41 127.99 169.23
Current liabilities 41.14 52.11 38.81 63.35
Total Liabilities 292.28 473.83 527.35 702.56
Assets
Net Block 136.58 263.93 260.57 352.61
Capital WIP 2.71 9.26 8.18 34.1
Intangible WIP 0 0.37 1.24 0.07
Investments 4.16 4.87 4.87 4.87
Loans & Advances 4.57 9.75 9.73 32.79
Other N/C Assets 3.09 2.39 8.66 13.79
Current Assets 141.18 183.26 234.1 264.33
Total Assets 292.28 473.83 527.35 702.56
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 70.41 81.75 109.59 144.38
Adjustment 23.94 50.69 52.55 56.06
Changes in Assets & Liabilities 1.01 -0.69 -3.13 -5.75
Tax Paid -18.81 -23.09 -31.17 -39.17
Operating Cash Flow 76.56 108.66 127.84 155.51
Investing Cash Flow -91.04 -34.31 -128.82 -126.72
Financing Cash Flow 7.83 -28.08 -48.19 -24.72
Net Cash Flow -6.65 46.27 -49.17 4.08

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Promoters 54.78 55.04 55.01 55.01 55.01
surendranath reddy... 33.04 33.04 32.78 32.78 32.78
suprita s reddy 8.99 8.99 9.00 9.00 9.00
sunil chandra kond... 8.92 8.92 8.93 8.93 8.93
geetha reddy sura 3.98 3.98 3.98 3.98 3.98
birudavolu vishnu ... 0.03 0.03 0.03 0.03 0.03
birudavolu gautam 0.01 0.01 0.02 0.01 0.01
sanjay kumar p v 0.01 - 0.02 0.01 0.01
manjula kankanti - - 0.01 0.01 0.01
p madhulika 0.01 0.01 0.01 0.01 0.01
venkata sanjay kum... - 0.01 - - -
PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Investors 45.22 44.96 44.99 44.99 44.99
karakoram limited - - 9.64 9.64 -
axis mutual fund t... - - - - 6.63
axis mutual fund t... - - - 6.34 -
axis mutual fund t... 5.45 4.88 1.62 - -
nippon life india ... - 5.75 - - -
nippon life india ... 5.53 - - - -
fidelity investmen... - - 1.05 3.82 3.82
wasatch emerging i... 3.52 3.52 - - 3.12
al mehwar commerci... 3.00 3.00 - - 2.29
nippon life india ... - - - 1.92 2.21
fidelity investmen... 1.86 1.73 - - 1.82
aberdeen standard ... 1.56 1.86 - 1.56 1.56
aditya birla sun l... - - - 1.70 -
mirae asset health... - - - 1.75 -
fidelity funds - i... 1.72 1.72 1.03 1.72 1.72
aditya birla sun l... - - 1.71 - -
aberdeen new india... 1.31 1.51 - - 1.27
the india fund inc 1.35 1.47 - 1.02 1.35
wasatch internatio... 1.11 1.11 - - 1.22
goldman sachs (sin... - - 1.07 1.01 -
abu dhabi investme... - 1.03 - - -
abu dhabi investme... - - - 1.01 1.01
destinations inter... - - - - 1.01

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Company News

Vijaya Diagnostic Centre informs about analyst meet25 May 2023, 3:19PM Vijaya Diagnostic Centre informs about institutional investor meeting27 Feb 2023, 12:33PM Vijaya Diagnostic Centre informs about investors meet20 Feb 2023, 3:05PM Vijaya Diagnostic - Quaterly Results13 Feb 2023, 2:08PM Vijaya Diagnostic - Quaterly Results13 Feb 2023, 2:08PM Vijaya Diagnostic - Quaterly Results13 Feb 2023, 2:08PM Vijaya Diagnostic Centre informs about investor meet 11 Feb 2023, 12:27PM Vijaya Diagnostic Centre informs about related party transactions24 Nov 2022, 5:04PM Vijaya Diagnostic Centre informs about transcript of earnings call18 Nov 2022, 12:52PM Vijaya Diagnostic - Quaterly Results10 Nov 2022, 1:49PM Vijaya Diagnostic - Quaterly Results10 Nov 2022, 1:49PM Vijaya Diagnostic - Quaterly Results10 Nov 2022, 1:49PM Vijaya Diagnostic Centre informs about disclosure 26 Sep 2022, 4:41PM Vijaya Diagnostic Centre informs about investors meet14 Sep 2022, 10:42AM Vijaya Diagnostic Centre informs analyst meet25 Aug 2022, 12:26PM Vijaya Diagnostic Centre submits newspaper publication 10 Aug 2022, 12:42PM Vijaya Diagnostic - Quaterly Results9 Aug 2022, 1:28PM Vijaya Diagnostic - Quaterly Results9 Aug 2022, 1:28PM Vijaya Diagnostic - Quaterly Results9 Aug 2022, 1:28PM Vijaya Diagnostic Centre informs about analyst meet13 Jun 2022, 11:52AM Vijaya Diagnostic Centre informs about newspaper publication 28 May 2022, 12:15PM Vijaya Diagnostic - Quaterly Results26 May 2022, 9:09PM Vijaya Diagnostic - Quaterly Results26 May 2022, 9:09PM Vijaya Diagnostic Centre informs about schedule of analyst meet2 May 2022, 10:29AM Vijaya Diagnostic Centre informs about analyst meet10 Mar 2022, 12:40PM Vijaya Diagnostic Centre informs about disclosure10 Mar 2022, 9:29AM Karakoram offloads shares of Vijaya Diagnostic Centre worth over Rs 332 crore8 Mar 2022, 3:44PM Vijaya Diagnostic Centre informs about analyst meet2 Mar 2022, 2:58PM Vijaya Diagnostic Centre informs about earnings conference call11 Feb 2022, 12:59PM Vijaya Diagnostic Centre informs about newspaper publication5 Feb 2022, 4:06PM Vijaya Diagnostic - Quaterly Results4 Feb 2022, 5:21PM Vijaya Diagnostic - Quaterly Results4 Feb 2022, 5:21PM Vijaya Diagnostic - Quaterly Results4 Feb 2022, 5:21PM Vijaya Diagnostic Centre informs about board meeting28 Jan 2022, 1:13PM Vijaya Diagnostic Centre informs about disclosure13 Jan 2022, 4:39PM Vijaya Diagnostic Centre submits newspaper publication 11 Dec 2021, 11:26AM Vijaya Diagnostic Centre informs about analyst meet 9 Dec 2021, 4:51PM Vijaya Diagnostic Centre informs about disclosure6 Dec 2021, 4:19PM Vijaya Diagnostic Centre informs about analyst meet 17 Nov 2021, 1:50PM Vijaya Diagnostic - Quaterly Results8 Nov 2021, 5:40PM Vijaya Diagnostic Centre coming with an IPO to raise upto Rs 1895 crore28 Aug 2021, 10:51AM Vijaya Diagnostics Centre to hit capital market on September 1 26 Aug 2021, 1:33PM

Vijaya Diagnostic Stock Price Analysis and Quick Research Report. Is Vijaya Diagnostic an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Vijaya Diagnostic and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 155.5114 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Vijaya Diagnostic has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Vijaya Diagnostic , the EPS growth was 30.529529812984 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Vijaya Diagnostic has OPM of 44.3257874113981 % which is a good sign for profitability.
     
  • ROE: Vijaya Diagnostic have a healthy ROE of 26.1204705394561 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Vijaya Diagnostic

X